Soy isoflavones and virus infections

Journal of Nutritional Biochemistry

Volumn 20, Issue 8, 2009, Pages 563-569

  Andres, Aline ^a   Donovan, Sharon M ^b   Kuhlenschmidt, Mark S ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Genistein; Infections; Isoflavones; Virus

Indexed keywords

5,6,7 TRIMETHOXYFLAVONE; CYTOKINE; DOUBLE STRANDED DNA; DOUBLE STRANDED RNA; FLAVONOID; GENISTEIN; IRISOLIDONE; ISOFLAVONE; ISOFLAVONE DERIVATIVE; ISOKAEMPFERIDE; KAEMPFEROL; LUTEOLIN; QUERCETIN; TORVANOL A; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ADENOVIRUS; ANTIVIRAL ACTIVITY; ARTERIVIRUS; BIOASSAY; CYTOKINE RELEASE; DNA VIRUS; HERPES SIMPLEX VIRUS; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW; RNA VIRUS; ROTAVIRUS; SIGNAL TRANSDUCTION; SOYBEAN; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; DIET; DISEASE MODELS, ANIMAL; FLAVONOIDS; GENISTEIN; HUMANS; ISOFLAVONES; PHYTOESTROGENS; SOYBEANS; SPECIES SPECIFICITY; VIRUS DISEASES; VIRUSES;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; ROTAVIRUS; SIMPLEXVIRUS;

EID: 67649827710     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.04.004     Document Type: Review

References (67)

1. Munro I.C., Harwood M., Hlywka J.J., Stephen A.M., Doull J., Flamm W.G., et al. Soy isoflavones: a safety review. Nutr Rev 61 (2003) 1-33
2. Cassidy A., Brown J.E., Hawdon A., Faughnan M.S., King L.J., Millward J., et al. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 136 (2006) 45-51
3. Dixon R.A. Phytoestrogens. Annu Rev Plant Biol 55 (2004) 225-261
4. Cornwell T., Cohick W., and Raskin I. Dietary phytoestrogens and health. Phytochemistry 65 (2004) 995-1016
5. Andlauer W., Kolb J., Stehle P., and Furst P. Absorption and metabolism of genistein in isolated rat small intestine. J Nutr 130 (2000) 843-846
6. Chen A.C., Berhow M.A., Tappenden K.A., and Donovan S.M. Genistein inhibits intestinal cell proliferation in piglets. Pediatr Res 57 (2005) 192-200
7. 2/M cell cycle arrest. J Nutr 134 (2004) 1303-1308
8. Tanaka H., Sato M., Oh-Uchi T., Yamaguchi R., Etoh H., Shimizu H., et al. Antibacterial properties of a new isoflavonoid from Erythrina poeppigiana against methicillin-resistant Staphylococcus aureus. Phytomedicine 11 (2004) 331-337
9. Sfakianos J., Coward L., Kirk M., and Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127 (1997) 1260-1268
10. Zhang Y., Hendrich S., and Murphy P.A. Glucuronides are the main isoflavone metabolites in women. J Nutr 133 (2003) 399-404
11. Ronis M.J., Little J.M., Barone G.W., Chen G., Radominska-Pandya A., and Badger T.M. Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract. J Med Food 9 (2006) 348-355
12. Setchell K.D., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 132 (2002) 3577-3584
13. Faughnan M.S., Hawdon A., Ah-Singh E., Brown J., Millward D.J., and Cassidy A. Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. Br J Nutr 91 (2004) 567-574
14. Gu L., House S.E., Prior R.L., Fang N., Ronis M.J., Clarkson T.B., et al. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr 136 (2006) 1215-1221
15. Xiao C.W. Health effects of soy protein and isoflavones in humans. J Nutr 138 (2008) 1244S-1249S
16. Barnes S. Soy isoflavones - phytoestrogens and what else?. J Nutr 134 (2004) 1225S-1228S
17. Ososki A.L., and Kennelly E.J. Phytoestrogens: a review of the present state of research. Phytother Res 17 (2003) 845-869
18. Dijsselbloem N., Vanden Berghe W., De Naeyer A., and Haegeman G. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 68 (2004) 1171-1185
19. Chen A., and Rogan W.J. Isoflavones in soy infant formula: a review of evidence for endocrine and other activity in infants. Annu Rev Nutr 24 (2004) 33-54
20. Omoni A.O., and Aluko R.E. Soybean foods and their benefits: potential mechanisms of action. Nutr Rev 63 (2005) 272-283
21. Sadowska-Krowicka H., Mannick E.E., Oliver P.D., Sandoval M., Zhang X.J., Eloby-Childess S., et al. Genistein and gut inflammation: role of nitric oxide. Proc Soc Exp Biol Med 217 (1998) 351-357
22. Choi C., Cho H., Park J., Cho C., and Song Y. Suppressive effects of genistein on oxidative stress and NFkappaB activation in RAW 264.7 macrophages. Biosci Biotechnol Biochem 67 (2003) 1916-1922
23. Tabary O., Escotte S., Couetil J.P., Hubert D., Dusser D., Puchelle E., et al. Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells. Am J Pathol 155 (1999) 473-481
24. Nozawa Y., Nishihara K., Peek R.M., Nakano M., Uji T., Ajioka H., et al. Identification of a signaling cascade for interleukin-8 production by Helicobacter pylori in human gastric epithelial cells. Biochem Pharmacol 64 (2002) 21-30
25. Baxa D.M., and Yoshimura F.K. Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha. Biochem Pharmacol 66 (2003) 1009-1018
26. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262 (1987) 5592-5595
27. Lamartiniere C.A. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 71 (2000) 1705S-1707S
28. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19 (2000) 5406-5417
29. Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., et al. The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80 (2002) 239-256
30. 2+ uptake via PKC, cAMP, and p38 MAPK in mouse embryonic stem cells. Life Sci 76 (2005) 2903-2919
31. Klein C.B., and King A.A. Genistein genotoxicity: critical considerations of in vitro exposure dose. Toxicol Appl Pharmacol 224 (2007) 1-11
32. Salti G.I., Grewal S., Mehta R.R., Das Gupta T.K., Boddie Jr. A.W., and Constantinou A.I. Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur J Cancer 36 (2000) 796-802
33. Li E., Stupack D.G., Brown S.L., Klemke R., Schlaepfer D.D., and Nemerow G.R. Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 275 (2000) 14729-14735
34. Chiang L.C., Chiang W., Liu M.C., and Lin C.C. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J Antimicrob Chemother 52 (2003) 194-198
35. Vela E.M., Bowick G.C., Herzog N.K., and Aronson J.F. Genistein treatment of cells inhibits arenavirus infection. Antiviral Res 77 (2008) 153-156
36. Akula S.M., Hurley D.J., Wixon R.L., Wang C., and Chase C.C. Effect of genistein on replication of bovine herpesvirus type 1. Am J Vet Res 63 (2002) 1124-1128
37. Lecot S., Belouzard S., Dubuisson J., and Rouille Y. Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis. J Virol 79 (2005) 10826-10829
38. Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 78 (2004) 11334-11339
39. Fukuda M., and Longnecker R. Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J Virol 79 (2005) 8655-8660
40. Yura Y., Yoshida H., and Sato M. Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase. Arch Virol 132 (1993) 451-461
41. Lyu S.Y., Rhim J.Y., and Park W.B. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res 28 (2005) 1293-1301
42. Arthan D., Svasti J., Kittakoop P., Pittayakhachonwut D., Tanticharoen M., and Thebtaranonth Y. Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of Solanum torvum. Phytochemistry 59 (2002) 459-463
43. Amoros M., Simoes C.M., Girre L., Sauvager F., and Cormier M. Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod 55 (1992) 1732-1740
44. Hayashi K., Hayashi T., Otsuka H., and Takeda Y. Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir. J Antimicrob Chemother 39 (1997) 821-824
45. Evers D.L., Chao C.F., Wang X., Zhang Z., Huong S.M., and Huang E.S. Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antiviral Res 68 (2005) 124-134
46. Sharma-Walia N., Naranatt P.P., Krishnan H.H., Zeng L., and Chandran B. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J Virol 78 (2004) 4207-4223
47. Stantchev T.S., Markovic I., Telford W.G., Clouse K.A., and Broder C.C. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Res 123 (2007) 178-189
48. Kim S.Y., Kim D.H., Hyun J.W., Henson J.W., and Kim H.S. Irisolidone, an isoflavone metabolite, represses JC virus gene expression via inhibition of Sp1 binding in human glial cells. Biochem Biophys Res Commun 344 (2006) 3-8
49. Kubo Y., Ishimoto A., and Amanuma H. Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells. Arch Virol 148 (2003) 1899-1914
50. Robin V., Irurzun A., Amoros M., Boustie J., and Carrasco L. Antipoliovirus flavonoids from Psiadia dentata. Antiviral Chem Chemother 12 (2001) 283-291
51. Greiner L.L., Stahly T.S., and Stabel T.J. The effect of dietary soy genistein on pig growth and viral replication during a viral challenge. J Anim Sci 79 (2001) 1272-1279
52. Rixon H.W., Brown G., Murray J.T., and Sugrue R.J. The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen-activated protein kinase p38-dependent tyrosine kinase activity during virus infection. J Gen Virol 86 (2005) 375-384
53. Dangoria N.S., Breau W.C., Anderson H.A., Cishek D.M., and Norkin L.C. Extracellular simian virus 40 induces an ERK/MAP kinase-independent signalling pathway that activates primary response genes and promotes virus entry. J Gen Virol 77 Pt 9 (1996) 2173-2182
54. Pelkmans L., Puntener D., and Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296 (2002) 535-539
55. Salvati A.L., De Dominicis A., Tait S., Canitano A., Lahm A., and Fiore L. Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus. Antimicrob Agents Chemother 48 (2004) 2233-2243
56. Genovese D., Conti C., Tomao P., Desideri N., Stein M.L., Catone S., et al. Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Res 27 (1995) 123-136
57. Conti C., Genovese D., Santoro R., Stein M.L., Orsi N., and Fiore L. Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro. Antimicrob Agents Chemother 34 (1990) 460-466
58. Tait S., Salvati A.L., Desideri N., and Fiore L. Antiviral activity of substituted homoisoflavonoids on enteroviruses. Antiviral Res 72 (2006) 252-255
59. Andres A., Donovan S.M., Kuhlenschmidt T.B., and Kuhlenschmidt M.S. Isoflavones at concentrations present in soy infant formula inhibit rotavirus infection in vitro. J Nutr 137 (2007) 2068-2073
60. Mitrocotsa D., Mitaku S., Axarlis S., Harvala C., and Malamas M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med 66 (2000) 377-379
61. Setchell K.D., Zimmer-Nechemias L., Cai J., and Heubi J.E. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 68 (1998) 1453S-1461S
62. Lin Y.M., Flavin M.T., Schure R., Chen F.C., Sidwell R., Barnard D.L., et al. Antiviral activities of biflavonoids. Planta Med 65 (1999) 120-125
63. Fisher D., Baird J., Payne L., Lucas P., Kleijnen J., Roberts H., et al. Are infant size and growth related to burden of disease in adulthood? A systematic review of literature. Int J Epidemiol 35 (2006) 1196-1210
64. Liu A.L., Wang H.D., Lee S.M., Wang Y.T., and Du G.H. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg Med Chem 16 (2008) 7141-7147
65. Formica J.V., and Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33 (1995) 1061-1080
66. Greiner L.L., Stahly T.S., and Stabel T.J. The effect of dietary soy daidzein on pig growth and viral replication during a viral challenge. J Anim Sci 79 (2001) 3113-3119
67. Erdman Jr. J.W., Badger T.M., Lampe J.W., Setchell K.D., and Messina M. Not all soy products are created equal: caution needed in interpretation of research results. J Nutr 134 (2004) 1229S-1233S